Science-Driven API Manufacturing for a Healthier Tomorrow
Alexander Lifesciences is an Indian bulk drug manufacturer dedicated to the synthesis and supply of Active Pharmaceutical Ingredients and chemical intermediates — built on quality, process excellence, and cost integrity.
Your Upstream Manufacturing Partner
Established in 2026 by industry professionals with over 15 years of experience, Alexander Lifesciences Private Limited operates as a focused, science-driven organisation headquartered in Hyderabad, India.
We serve generic drug formulators, innovator pharmaceutical companies, and specialty chemical buyers — both domestically and in export markets. Our facilities are designed and operated in compliance with current Good Manufacturing Practices (cGMP) and aligned with ICH Q7 guidelines.
From our first year of operations, we have approached the bulk drug business not merely as a manufacturing function, but as a scientific responsibility — where the purity and reliability of every batch has a direct bearing on the quality of medicines that reach patients.
Learn More About Us
Built for Precision. Priced for Partnership.
Our lean structure is a deliberate choice — direct oversight of every process, rapid response to client requirements, and genuine technical partnerships.
cGMP Compliance
Manufacturing aligned with ICH Q7 guidelines and inspected by Telangana Drug Control Administration.
Process Chemistry
Strong synthetic route development, process scale-up, and route optimisation at every stage.
Cost Integrity
Transparent, competitive pricing without compromising regulatory standards or product quality.
Global Reach
Serving domestic and export markets with capability for USFDA, EDQM, TGA, and other registrations.
APIs, Intermediates & Crown Ethers
We manufacture a wide range of Active Pharmaceutical Ingredients across therapeutic categories including antiparkinsonian, antihypertensive, antifungal, anticonvulsant, and more — alongside an extensive catalogue of chemical intermediates.
- 22+ Commercial APIs — available for supply with DMF/CTD documentation where applicable
- 36 Products Under Development — expanding our therapeutic portfolio
- 57 Intermediates — supporting downstream API synthesis globally
- Crown Ethers — 15-Crown-5, 18-Crown-6, and Dibenzo 18-Crown-6
State-of-the-Art cGMP Facility
Our sprawling 9-acre facility in Hyderabad produces APIs and intermediates under cGMP conditions — built to global standards and inspected by the Telangana Drug Control Administration.
Equipped with 30 SS/GL reactors (500L–5000L), dedicated hydrogenation, corrosive, and distillation blocks, integrated QC labs, stability chambers, and comprehensive utility systems.
Explore Our Facility
Ready to Partner with Us?
Whether you need a reliable API supplier or custom intermediate synthesis, our team is ready to discuss your requirements.
Get in Touch